Camber Pharmaceuticals recalled one lot of a pneumonia medicine after finding it might be contaminated with the Bacillus cereus bacteria.
The risk statement in Camber’s recall notice, written March 13 and posted by the FDA Friday, says: “In the population most at risk, immunocompromised population, there is a reasonable probability that microbial contamination of Atovaquone Oral Suspension can result in disseminated, life threatening infections such as endocarditis and necrotizing soft tissue infections.
READ MORE: A Miami company’s children’s ADHD medicine might not work. There’s a national recall
This covers Atovaquone Oral Suspension 750 mg/5 ml, lot No. E220182 with an expiration date of 12/2023. It went to retail and mail order pharmacies, wholesalers and distributors.
If you have this product, return it to the pharmacy for a refund and notify your medical professional. If you have questions about this recall, reach out to Inmar, which is handling the recall for Camber, by emailing rxrecalls@inmar.com or calling 877-597-0878, Monday through Friday, 9 a.m. to 5 p.m., Eastern time.
If you’ve had any medical problems from this or any other drug, first see a medical professional. Then let the FDA know via its MedWatch Adverse Event page or by filling out a form you can get by calling 800-332-1088. Only then, do you let the manufacturer know.
[ad_2]
Source link
